VERAXA Biotech and Voyager file F-4 registration for merger
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC
July 17, 2025 8:55 AM EDTZURICH, July 17, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (VERAXA or the "Company"), an emerging leader in designing novel cancer therapies, and Voyager Acquisition Corp., Â a Cayman Islands exempted company and special purpose acquisition company targeting the healthcare sector (NASDAQ:VACH, Voyager or... More
